Ebos Group (ASX:EBO) Interest Expense: A$-91 Mil (TTM As of Dec. 2025)

What is Ebos Group Interest Expense?

Ebos Group ASX:EBO +3.13% 77 Interest Expense is A$-91 Mil as of Dec. 2025. GuruFocus rates ASX:EBO with a GF Score™ of 77/100 and a GF Value™ of A$31.51 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Ebos Group's interest expense for the six months ended in Dec. 2025 was A$ -47 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2025 was A$-91 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Ebos Group's Operating Income for the six months ended in Dec. 2025 was A$ 193 Mil. Ebos Group's Interest Expense for the six months ended in Dec. 2025 was A$ -47 Mil. Ebos Group's Interest Coverage for the quarter that ended in Dec. 2025 was 4.09. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Ebos Group (ASX:EBO) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Ebos Group's Interest Expense for the six months ended in Dec. 2025 was A$-47 Mil. Its Operating Income for the six months ended in Dec. 2025 was A$193 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2025 was A$1,754 Mil.

Ebos Group's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2025 )	/	Interest Expense (Q: Dec. 2025 )
	=	-1	*	193.419	/	-47.306
	=	4.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Ebos Group Interest Expense Historical Data

* Premium members only.

The historical data trend for Ebos Group's Interest Expense can be seen below:

Ebos Group Interest Expense Chart

Ebos Group Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Jun25

Interest Expense

Get a 7-Day Free Trial

-20.62

-23.00

-67.46

-84.14

-89.25

Ebos Group Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Interest Expense	Get a 7-Day Free Trial															-41.16	-43.20	-44.21	-44.09	-47.31

77GF Score

Ebos Group Ltd ASX:EBO

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Ebos Group Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-91 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of A$-91 Mil mean?

Ebos Group (ASX:EBO) has a Interest Expense of A$-91 Mil as of Dec. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on Ebos Group and its competitors.

Is Ebos Group's Interest Expense too high?

Ebos Group's current Interest Expense is A$-91 Mil. Overall, Ebos Group has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Ebos Group's Interest Expense compare to MCK and CAH?

Ebos Group's Interest Expense of A$-91 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Medical Distribution company?

A good Interest Expense depends on the Medical Distribution industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Ebos Group and its competitors. Ebos Group's current Interest Expense is A$-91 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Ebos Group stock overvalued right now?

Based on GuruFocus' analysis, Ebos Group (ASX:EBO) is currently considered Significantly Undervalued. The stock's GF Value™ is A$31.51, compared to a current price of A$17.47 — trading 44.6% below its estimated fair value. The current Interest Expense is A$-91 Mil. Ebos Group's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Ebos Group (ASX:EBO), the current Interest Expense is A$-91 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ebos Group (ASX:EBO) Overvalued in 2026?

Based on GuruFocus' analysis, Ebos Group stock appears to be undervalued. The current stock price of A$17.47 is trading 44.6% below its estimated GF Value™ of A$31.51. GuruFocus considers Ebos Group to be Significantly Undervalued.

Key valuation signals for ASX:EBO:

Interest Expense: A$-91 Mil
GF Value™: A$31.51 vs. price of A$17.47 (44.6% below fair value)
GF Score™: 77/100 with 4 warning signs

No single metric tells the full story. See the ASX:EBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ebos Group Business Description

Industry Healthcare Medical Distribution

Comparable Companies MCK CAH COR ASX:SIG HSIC SHSE:601607 HKSE:01099 XSWX:GALE SHSE:600332 SHSE:600998 TSE:7459 OSTO:ASKER MIL:AMP SHSE:600511 IST:SELEC TSE:2784 SHSE:600739 TSE:9987 SHSE:600056 SZSE:000028

Other Exchanges EBOSY:USA EBO:New Zealand EJG:Germany

Address 737 Bourke Street, Level 7, Docklands, Melbourne, VIC, AUS, 3008

Website https://www.ebosgroup.com

Ebos is the largest pharmaceutical wholesaler across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 50% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.

77GF Score

Get the complete analysis for ASX:EBO

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$17.47

Price

A$31.51

GF Value

View ASX:EBO Analysis

See Interest Expense data for all stocks →